Clinical Research Facility

Princeton, New Jersey 08540

We've found

3 trials

at this facility

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Status: Enrolling, Phase III
Updated: 8/10/2016

from

Princeton, NJ

Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)

Status: Enrolling, Phase II
Updated: 2/25/2016

from

Princeton, NJ

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Princeton, NJ

Use our guide to learn which trials are right for you!